Title : Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibition.

Pub. Date : 2016 Nov

PMID : 27398626






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vorapaxar is a first-in-class, novel antiplatelet agent that acts by antagonizing the PAR-1 receptor, inhibiting thrombin-mediated platelet activation. vorapaxar coagulation factor II thrombin receptor Homo sapiens